Condoms Don’t Always Prevent Herpes Infection; polyDNA Monthly Survey Results Show Public isn't Aware of Facts

During one particular study, it was noted that "24 sets of condoms were tested and all failed." (Human Life International, 2010) [1]

Rochester, NY (PRWEB) March 27, 2013

As new results from a monthly survey come in, polyDNA has learned that the public is unaware that genital herpes can be transmitted even when using condoms.

For instance, the public did not realize that the CDC notes on its website, that while condom use can reduce the risk of herpes transmission, “outbreaks can occur in areas that are not covered by a condom.” [2]

Another study showed that "Spillage from condoms occurs as much as 65% to 75% of the time."[3] and “Higher per-use rates of breakage or slippage (of condoms) among non-main partners were also observed in our analysis involving heterosexual partners during vaginal sex .” [4]

This is also one reason that Bill Gates, the Microsoft founder and philanthropist has promised to offer a $100,000 grant through the Bill and Melinda Gates Foundation to anyone, from students and scientists to entrepreneurs, who can invent a next-generation condom. [5]

polyDNA found that the public was simply unaware that because of issues such as spillage, slippage, and breakage, condoms may fail, thus increasing the risk of herpes transmission. Moreover, the public also did not realize that herpes may be transmitted through skin-to-skin contact around areas the condoms do not cover.

The public should be aware of the relationship between safer sex practices and genital herpes prevention. polyDNA recommends boosting the immune system against a latent herpes infection through the use of a scientific, all natural remedy. That remedy is Gene-Eden-VIR. A recent post marketing clinical study showed that Gene-Eden-VIR is effective against the latent herpes virus. [6]

This all-natural product was scientifically designed to help the human body maintain low concentrations of the dormant or latent herpes virus.

By helping the body's immune system target the latent herpes virus, people also lower their risk of developing fever blisters, cold sores, or genital herpes symptoms.

Gene-Eden-VIR is highly effective against the latent herpes virus, each ingredient was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent forms of both HSV-1 and HSV-2. [7]

In addition, each bottle is GMP Certified.

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com.

References:

1. http://www.hli.org/index.php/condoms/139

2. http://www.cdc.gov/std/herpes/STDFact-Herpes.htm

3. Bjorklund and Gordon. Univ of Manitoba. Nov. 1990.

4. http://www.tandfonline.com/doi/full/10.1080/09540121.2012.668285

5. http://www.scienceworldreport.com/articles/5769/20130325/bill-gates-offers-1-m-invent-worlds-next-generation-condom.htm

6: http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php

7: http://www.gene-eden-kill-virus.com/studies.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.

Mike Davis
PolyDNA
5852509999
Email Information

View the original article here

Condoms Associated With Moderate Protection Against Herpes Simplex Virus 2

ScienceDaily (July 13, 2009) — Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies.

Herpes simplex virus 2 (HSV-2) typically causes genital herpes, a chronic, life-long, viral infection. Although studies indicate that consistent condom use reduces the spread of HIV and other sexually transmitted diseases such as chlamydia and gonorrhea, the effectiveness of preventing the transmission of HSV-2 through condom use is less certain, according to background information in the article.

Emily T. Martin, M.P.H., Ph.D., of Children's Hospital Research Institute and the University of Washington, Seattle, and colleagues analyzed data from six HSV-2 studies to assess the effectiveness of condom use in preventing the virus. The studies included three candidate HSV-2 vaccine studies, an HSV-2 drug study, an observational sexually transmitted infection (STI) incidence study and a behavioral STI intervention study. These yielded results from 5,384 HSV-2-negative individuals (average age 29) at baseline for a combined total of 2,040,894 follow-up days.

More than 66 percent of those who took part in the six studies were male, 60.4 percent were white, 94.1 percent were heterosexual and most reported no prior STIs.

A total of 415 of the individuals acquired HSV-2 during follow-up. "Consistent condom users [used 100 percent of the time] had a 30 percent lower risk of HSV-2 acquisition compared with those who never used condoms," the authors write. "Risk of HSV-2 acquisition decreased by 7 percent for every additional 25 percent of the time that condoms were used during anal or vaginal sex." The risk of acquiring the virus increased significantly with increasing frequency of unprotected sex acts. There were no significant differences found in condom effectiveness between men and women.

"Based on findings of this large analysis using all available prospective data, condom use should continue to be recommended to both men and women for reducing the risk of HSV-2 acquisition," the authors conclude. "Although the magnitude of the protective effect was not as large as has been observed with other STIs, a 30 percent reduction in HSV-2 incidence can have a substantial benefit for individuals as well as a public health impact at the population level."

Funding for this project was provided by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases. 

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by JAMA and Archives Journals.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

Emily T. Martin, MPH; Elizabeth Krantz, MS; Sami L. Gottlieb, MD, MSPH; Amalia S. Magaret, PhD; Andria Langenberg, MD; Lawrence Stanberry, MD, PhD; Mary Kamb, MD, MPH; Anna Wald, MD, MPH. A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition. Arch Intern Med, 2009;169(13):1233-1240 [link]

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

View the original article here